The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
- 22 March 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (12), 2738-2745
- https://doi.org/10.1182/blood-2011-08-371112
Abstract
Community respiratory viruses are significant causes of morbidity and mortality in patients with leukemia and hematopoietic stem cell transplant (HSCT) recipients. Data on characteristics and outcomes of parainfluenza virus (PIV) infections in these patients are limited. We reviewed the records of patients with leukemia and HSCT recipients who developed PIV infections to determine the characteristics and outcomes of such infections. We identified 200 patients with PIV infections, including 80 (40%) patients with leukemia and 120 (60%) recipients of HSCT. At presentation, most patients (70%) had an upper respiratory tract infection and the remaining patients (30%) had pneumonia. Neutropenia, APACHE II score more than 15, and respiratory coinfections were independent predictors of progression to pneumonia on multivariate analysis. Overall mortality rate was 9% at 30 days after diagnosis and 17% among patients who had PIV pneumonia, with no significant difference between patients with leukemia and HSCT recipients (16% vs 17%). On multivariate analysis, independent predictors of death were relapsed or refractory underlying malignancy, APACHE II score more than 15, and high-dose steroid use. Patients with leukemia and HSCT are at risk for serious PIV infections, including PIV pneumonia, with a significant mortality rate. We identified multiple risk factors for progression to pneumonia and death.Keywords
This publication has 23 references indexed in Scilit:
- Parainfluenza Virus Infections in Children With Hematologic MalignanciesThe Pediatric Infectious Disease Journal, 2011
- The Remaining Challenge of PneumoniaThe Pediatric Infectious Disease Journal, 2011
- Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantationHaematologica, 2009
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation RecipientsMedicine, 2006
- Prospective Study of the Incidence, Clinical Features, and Outcome of Symptomatic Upper and Lower Respiratory Tract Infections by Respiratory Viruses in Adult Recipients of Hematopoietic Stem Cell Transplants for Hematologic MalignanciesTransplantation and Cellular Therapy, 2005
- Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence?Journal of Clinical Virology, 2004
- Common community respiratory viruses in patients with cancerCancer, 2003
- Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot studyBone Marrow Transplantation, 2001
- Parainfluenza virus infection in adult bone marrow transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993